cetuximab相关论文
目的:探讨西妥昔单抗联合三维适形放疗在中晚期食管癌患者中的疗效及对血清肿瘤标志物水平、新生血管指标水平、生存情况的影响。......
Autophagy-related proteins Beclin-1 and LC3 predict cetuximab efficacy in advanced colorectal cancer
...
...
Phosphatase and tensin homolog expression related to cetuximab effects in colorectal cancer patients
...
Cetuximab tagged and oleic acid modified chitosan nanoparticles for tumor targeted quercetin deliver
Nanoparticles (NPs) have shown great potentials in tumor chemotherapy.Quercetin (QUE) has been reported as a natural bio......
Risk of fatal adverse events associated with bevacizumab,cetuximab,and panitumumab in 25,000 patient
Objective The present meta-analysis was conducted to evaluate the fatal adverse events(FAEs)of targeted drugs including ......
Retrospective study comparing anti-EGFR monoclonal antibody plus cisplatin-based chemoradiotherapy v
...
Cetuximab versus Bevacizumab in advanced colorectal cancer:a real-world exploration of maintenance t
...
...
Bovine serum albumin nanoparticles surface-adsorbing cetuximab-doxorubicin conjugates induce enhance
Specific modification of carriers to achieve targeted transport of chemotherapeutics into malignant tumors is critical f......
EGFR-targeting antibodies enhance the irradiation response of esophageal cancer cell lines of differ
There is an established relationship between epidermal growth factor receptor (EGFR) expression and tumor cell prolifera......
A Phase Ⅱ Clinical Trial of Concurrent Helical Tomotherapy plus Cetuximab Followed by Adjuvant Chemo
Purpose:The present clinical trial was designed to evaluate the efficacy and safety of concurrent helical tomotherapy (H......
Comparison of bevacizumab with cetuximab as the first? line bio? chemotherapy for patients with meta
The present observational cohort study was designed to elucidate the efficacy and safety profile of bevacizumab or cetux......
Combined oridonin,a natural and safe kaurene diterpenoid isolated from Rabdosia rubescens,and cetuximab,an anti-EGFR mon......
对于表皮生长因子受体(EGFR)突变的肺癌病人来说，耐药性是靶向药物络氨酸激酶抑制剂(TKI)有效治疗的主要障碍.我们设计了cetuximab......
Combination of Oridonin and Cetuximab Synergistically Exerts Apoptosis and G2M Arrest on Laryngeal S
Epidermal growth factor receptor(EGFR),a transmembrane glycoprotein,is expressed at high levels in a large proportio......
Cost-effectiveness analysis of first-line cetuximab plus leucovorin,fluorouracil,and oxaliplatin(FOL
Objective Colorectal cancer(CRC)is a common malignant tumor of digestive tract,with a poor prognosis.Currently,thera......
C是人抗表皮生长因子受体(EGFR)的单克隆抗体,用于治疗结直肠癌及头颈部鳞状细胞癌。此药严重过敏反应发生率较高。该研究显示76例......
目的 观察西妥昔单抗联合化疗一线治疗K-RAS野生型晚期结直肠癌的临床疗效及安全性.方法 回顾性分析2008年2月- 2014年7月我院收治......
目的 探讨西妥昔单抗联合适形调强放疗对局部晚期鼻咽癌的临床疗效和安全性.方法 58例初治鼻咽癌患者随机分为治疗组和对照组.对照......
目的探讨对k-ras野生型结直肠癌肝转移患者应用西妥昔单抗联合mFOLFOX6方案一线治疗的临床效果及安全性。方法选择经病理组织学检......
美国FDA近日批准百时美施贵宝(BMS)和礼来公司合作开发的cetuximab(商品名:Erbitux,爱必妥)用于晚期或转移性头颈癌的治疗.研究显......
1例56岁男性患者,因鼻咽癌行放疗+西妥昔单抗分子靶向治疗。首次静脉滴注西妥昔单抗600 mg,此后400 mg/次,1次/周。首次用药后第11......
1例62岁男性直肠癌术后吻合口复发伴肝转移患者自2012年7月19日起接受西妥昔单抗(第1周：716 mg，第2～34周：447.5 mg；1次/周静脉滴注)单药......
目的评价西妥昔单抗联合化疗药与单用化疗药治疗晚期结直肠癌(ACRC)或转移性结直肠癌(mCRC)致严重不良反应(≥3级)的发生情况。方......
We report a 55-year-old male who developed advanced hepatic metastasis and peritoneal carcinomatosis after resection of ......
AIM: To investigate efficacy and safety of cetuximab combined with two chemotherapy regimens in patients with unresectab......
Objective: To observe the efficacy and safety of cetuximab combined with chemotherapy in advanced non-small-cell lung ca......
Objective: The combination of cetuximab with standard chemotherapy was not widely studied though it was recommended by N......
目的 评价西妥昔单抗联合化疗治疗消化系统肿瘤的疗效和安全性.方法 回顾性分析行西妥昔单抗联合化疗的35例结直肠癌(CRC)、11例进......
[目的]总结含西妥昔单抗(Cetuximab)方案治疗胃癌和食管癌的资料,探讨Cetuximab治疗胃癌或食管癌患者的初步疗效和安全性。[方法]......
[目的]总结cetuximab联合化疗治疗2例NSCLC的经验并同时综述文献,期望了解cetuximab治疗肺癌的现状。[方法]回顾性分析中山大学肿......
[目的]总结cetuximab联合化疗治疗2例NSCLC的经验并同时综述文献,期望了解cetuximab治疗肺癌的现状。[方法]回顾性分析中山大学肿......
FDA于2004年2月12日批准ImcloneSystems的抗癌新药Cetuximab(C225,商品名:Erbitux)用于治疗结直肠癌。Cetuximab为IgG1单克隆抗体,......
Objective:Cetuximab combined with chemotherapy has been used to treat non-small cell lung cancer (NSCLC) in recent years......
美国FDA近日批准百时美施贵宝(BMS)和礼来公司合作开发的cetuximab(商品名:Erbitux,爱必妥)用于晚期或转移性头颈癌的治疗。研究显......
美国FDA近日批准百时美施贵宝(BMS)和礼来公司合作开发的cetuximab(商品名:Erbitux,爱必妥)用于晚期或转移性头颈癌的治疗。研究显......
目的:调查我院使用西妥昔单抗的住院患者中该药不良反应的发生情况.方法:利用我院医院信息化系统及数字化病历管理系统,提取2012年......
原发性肝癌(以下简称肝癌)是世界第六位常见的恶性肿瘤。根据GLOBOCAN 2002年统计结果，全世界每年的肝癌新发例数为62.6万，其中我国......
Objective.:In patients with head and neck squamous cell carcinoma (HNSCC),cetuximab [a monoclonal antibody targeting epi......
,Specific targeting of nasopharyngeal carcinoma cell line CNE1 by C225-conjugated ultrasmall superpa
...
Mutations in the oncogene BRAF(V600E) are found in ～10％ of colorectal cancers (CRCs) and are associated with poor prognosi......
本论文的目的在于通过分别检测鼻咽癌肿瘤组织EGFR蛋白表达以及鼻咽癌患者相配对的原发灶和颈部淋巴结转移灶的EGFR蛋白表达和KRAS......
头颈部鳞癌发病机制是一个多阶段演变的过程,包括正常鳞状上皮基因突变、信号传导通路激活等,可导致增生、良性肿瘤、原位癌及恶变......
Cetuximab is a chimeric immunoglobulin G1 monoclonal antibody that targets the ligand-binding domain of the epidermal gr......
目的:分析西妥昔单抗联合适形调强放疗和化疗治疗鼻咽癌的临床疗效,毒性反应和预后因素。方法:纳入2006年3月至2011年3月在我院初......
目的:探讨表皮生长因子受体(EGFR)抑制剂在舌鳞癌多药耐药中的作用。方法:免疫细胞化学技术和Western blot方法检测舌癌细胞系Tca8......
Objective:To evaluate the efficacy and safety of cetuximab combined with chemotherapy in colorectal cancer (CRC).Methods......
Objective: Cetuximab is an effective medicine for colorectal cancer bearing wild type Kras. However, few studies of cetu......
with colorectal cancer treated by cetuximab-contained regimen, it showed that the monoclonal antibody was effective and ......
